NewMed Energy - Limited Partnership (TLV:NWMD)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,571.00
+8.00 (0.51%)
Aug 14, 2025, 3:41 PM IDT
Regulus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 380.7 | 51.2 | 29.1 | 22.4 | 220.2 | 69.98 | Upgrade |
Short-Term Investments | 7.7 | 333.3 | 157.6 | 395.9 | 120.7 | 169.37 | Upgrade |
Cash & Short-Term Investments | 388.4 | 384.5 | 186.7 | 418.3 | 340.9 | 239.35 | Upgrade |
Cash Growth | 28.82% | 105.94% | -55.37% | 22.71% | 42.43% | 2.06% | Upgrade |
Accounts Receivable | 146.5 | 267 | 232.2 | 246.8 | 175.6 | 151.23 | Upgrade |
Other Receivables | 103 | 75.6 | 98.5 | 86.3 | 50.6 | - | Upgrade |
Receivables | 249.5 | 342.6 | 376.9 | 346 | 239.8 | 165.57 | Upgrade |
Prepaid Expenses | - | 7 | 4.7 | 7 | - | 12.99 | Upgrade |
Total Current Assets | 637.9 | 734.1 | 568.3 | 771.3 | 580.7 | 417.9 | Upgrade |
Property, Plant & Equipment | 2,738 | 2,685 | 2,650 | 2,550 | 2,570 | 3,440 | Upgrade |
Long-Term Investments | 61.7 | 62.2 | 160.3 | 60.2 | 163.5 | 184.85 | Upgrade |
Other Long-Term Assets | 520.2 | 511.2 | 467.5 | 516.5 | 484.6 | 484.08 | Upgrade |
Total Assets | 3,957 | 3,992 | 3,846 | 3,939 | 3,850 | 4,585 | Upgrade |
Accounts Payable | - | 3.3 | 1.3 | 3.1 | 4.7 | - | Upgrade |
Accrued Expenses | - | 12.4 | 14.2 | 23.2 | 17.7 | 2.01 | Upgrade |
Short-Term Debt | 100 | - | 80 | - | - | - | Upgrade |
Current Portion of Long-Term Debt | - | 485.6 | - | 424.8 | - | 393.81 | Upgrade |
Current Portion of Leases | - | 0.3 | 0.3 | 0.3 | - | - | Upgrade |
Current Income Taxes Payable | 7.8 | 10.8 | 27.7 | - | 168.1 | 55.57 | Upgrade |
Other Current Liabilities | 108.2 | 90.6 | 87.5 | 130.2 | 194 | 114.66 | Upgrade |
Total Current Liabilities | 216 | 603 | 211 | 581.6 | 384.5 | 566.05 | Upgrade |
Long-Term Debt | 1,141 | 1,140 | 1,735 | 1,731 | 2,225 | 2,855 | Upgrade |
Long-Term Leases | - | 2 | 2.3 | 2.6 | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | 658.4 | 391.5 | 313.9 | 269.8 | 207.8 | - | Upgrade |
Other Long-Term Liabilities | 77 | 68.5 | 71.4 | 66.6 | 94.4 | 166.25 | Upgrade |
Total Liabilities | 2,093 | 2,205 | 2,334 | 2,652 | 2,912 | 3,587 | Upgrade |
Common Stock | 154.8 | 154.8 | 154.8 | 154.8 | 154.8 | 154.79 | Upgrade |
Retained Earnings | 1,738 | 1,661 | 1,386 | 1,163 | 814.4 | 891.52 | Upgrade |
Comprehensive Income & Other | -28.2 | -28.1 | -28.6 | -29.9 | -30.7 | -48.62 | Upgrade |
Shareholders' Equity | 1,865 | 1,787 | 1,513 | 1,287 | 938.5 | 997.7 | Upgrade |
Total Liabilities & Equity | 3,957 | 3,992 | 3,846 | 3,939 | 3,850 | 4,585 | Upgrade |
Total Debt | 1,241 | 1,628 | 1,818 | 2,159 | 2,225 | 3,249 | Upgrade |
Net Cash (Debt) | -852.9 | -1,243 | -1,631 | -1,740 | -1,884 | -3,009 | Upgrade |
Net Cash Per Share | -0.73 | - | -1.39 | -1.48 | -1.60 | -2.56 | Upgrade |
Filing Date Shares Outstanding | 1,174 | - | 1,174 | 1,174 | 1,174 | 1,174 | Upgrade |
Total Common Shares Outstanding | 1,174 | - | 1,174 | 1,174 | 1,174 | 1,174 | Upgrade |
Working Capital | 421.9 | 131.1 | 357.3 | 189.7 | 196.2 | -148.14 | Upgrade |
Book Value Per Share | 1.59 | - | 1.29 | 1.10 | 0.80 | 0.85 | Upgrade |
Tangible Book Value | 1,865 | 1,787 | 1,513 | 1,287 | 938.5 | 997.7 | Upgrade |
Tangible Book Value Per Share | 1.59 | - | 1.29 | 1.10 | 0.80 | 0.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.